"What we have done, for the first time, is to actually create human embryonic stem cells without destroying the embryo itself" So stated Robert Lanza on the Nature podcast on 23 August, when his group's research paper — whose summary implied the same achievement — was published online (I. Klimanskaya et al. Nature doi:10.1038ature05142; 2006). The paper attracted worldwide media excitement, particularly in Germany, where the law prevents scientists from working on newly derived human embryonic stem-cell lines. Shares in Lanza's company, Advanced Cell Technologies (ACT) in Worcester, Massachusetts, leapt five-fold in price in just 10 hours.
展开▼
